Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase 3b, double-blind, multicenter, randomized study to compare the efficacy and safety of single dose dalbavancin to a two dose regimen of dalbavancin for the treatment of acute bacterial skin and skin structure infections

Next Previous
Search
Trial Profile

A phase 3b, double-blind, multicenter, randomized study to compare the efficacy and safety of single dose dalbavancin to a two dose regimen of dalbavancin for the treatment of acute bacterial skin and skin structure infections

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 06 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dalbavancin (Primary)
  • Indications Bacterial infections; Skin and soft tissue infections
  • Focus Registrational; Therapeutic Use
  • Sponsors Durata Therapeutics

    • Most Recent Events

    • 08 Oct 2017 Results of a subgroup analysis assessing the efficacy and safety of dalbavancin as treatment for ABSSSI in patients with Systemic Inflammatory Response Syndrome, presented at the IDWeek 2017.
    • 08 Oct 2017 Results of post hoc subgroup analysis assessing efficacy of dalbavancin for ABSSSI in patients with and without diabetes presented at the IDWeek 2017
    • 08 Oct 2017 Results of subanalysis assessing efficacy and safety of dalbavancin for the treatment of ABSSSI among overweight and obese patients presented at the IDWeek 2017

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top